Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐ EAACI Guidelines—2024–2025 Revision: Part II —Guidelines on Oral and Ocular Treatments
Allergy · 2026-06 · 81 (6) · 1947-1970
DOI: 10.1111/all.70305 ↗Kurz gefasst
Leitlinie in der Zeitschrift Allergy, online erschienen am 24.03.2026. Verfasst von Rafael José Vieira und 59 weiteren Autor:innen. Beteiligte Einrichtung: MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Asthma, Anti-Allergic Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ARIA (Allergic Rhinitis and its Impact on Asthma), Montpellier, France, Advanced Research and Invention Agency.
Abstract (Originalsprache)
Background
Oral and ocular medications are frequently used in the treatment of allergic rhinitis (AR). As part of the update of the Allergic Rhinitis and its Impact on Asthma (ARIA)‐EAACI guidelines, this manuscript presents the ARIA‐EAACI 2024–2025 recommendations for oral and ocular treatments.
Methods
The ARIA‐EAACI 2024–2025 guideline panel issued recommendations following the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) evidence‐to‐decision framework. Several sources of evidence were used to inform panel judgements and recommendations, including systematic reviews, mHealth and pharmacovigilance data as well as a survey on costs.
Results
Eight guideline questions concerning oral treatments for AR and three questions concerning ocular treatments were addressed. These questions led to the recommendations. Overall, these questions concern the choice between different classes of medication. They also discuss the role of oral antihistamines (OAH), leukotriene receptor antagonists (LTRA), ocular antihistamines (OcAH) and ocular mast cell stabilisers. Four questions had not been previously evaluated in ARIA guidelines, while, for the other four, there was a change in the strength or directionality of the recommendations. Overall, these guidelines recommend using intranasal corticosteroids over OAH and using OAH over LTRA. Moreover, they suggest using OAH over OcAH and suggest being against adding LTRA to OAH. Finally, considerations for choosing between different individual OAHs are presented.
Conclusion
This ARIA‐EAACI 2024–2025 article supports patients, their caregivers and healthcare professionals in choosing oral and ocular treatments for AR. Decisions on treatment should consider the clinical variability of the disease, patients' values and the affordability of medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
- CINTESIS@RISE-Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.
- Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
- ARIA (Allergic Rhinitis and Its Impact on Asthma), Montpellier, France.
- Department of Health Research Methods, Evidence, and Impact & Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
ORCID-Profile: Rafael José Vieira, Jean Bousquet, Torsten Zuberbier, Antonio Bognanni, Maria Jose Torres, Mohamed H Shamji, Mário Morais-Almeida, G Walter Canonica, Leticia de Las Vecillas, Ludger Klimek, Olga Lourenço, Nikolaos G Papadopoulos, Marine Savouré, Sanna K Toppila-Salmi, Alvaro A Cruz, Mattia Giovannini, Tuomas Jartti, Miloš Jeseňák, Oliver Pfaar, Luo Zhang, Tari Haahtela, Ivan Cherrez-Ojeda, Arzu Yorgancioglu, Baharudin Abdullah, Maryam Ali Al-Nesf, Rita Amaral, Julijana Asllani
Förderung
- ARIA (Allergic Rhinitis and its Impact on Asthma), Montpellier, France
- Advanced Research and Invention Agency
Zitieren
APA
Vieira, R. J., Sousa-Pinto, B., Bousquet, J., Schünemann, H. J., Zuberbier, T., Bognanni, A., Togias, A., Samolinski, B., Valiulis, A., Williams, S., Bedbrook, A., Czarlewski, W., Torres, M. J., Shamji, M. H., Morais-Almeida, M., Canonica, G. W., Vecillas, L. L., Dykewicz, M. S., Jacomelli, C., …, & Asllani, J. (2026). Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐ EAACI Guidelines—2024–2025 Revision: Part II —Guidelines on Oral and Ocular Treatments. Allergy, 81(6), 1947-1970. https://doi.org/10.1111/all.70305
Vancouver
Vieira RJ, Sousa-Pinto B, Bousquet J, Schünemann HJ, Zuberbier T, Bognanni A, et al. Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐ EAACI Guidelines—2024–2025 Revision: Part II —Guidelines on Oral and Ocular Treatments. Allergy. 2026;81(6):1947-1970. doi:10.1111/all.70305
BibTeX
@article{Vieira2026,
author = {Vieira, Rafael José and Sousa-Pinto, Bernardo and Bousquet, Jean and Schünemann, Holger J and Zuberbier, Torsten and Bognanni, Antonio and Togias, Alkis and Samolinski, Boleslaw and Valiulis, Arunas and Williams, Sian and Bedbrook, Anna and Czarlewski, Wienczyslawa and Torres, Maria Jose and Shamji, Mohamed H and Morais-Almeida, Mário and Canonica, G Walter and Vecillas, Leticia de Las and Dykewicz, Mark S and Jacomelli, Cristina and Klimek, Ludger and Leemann, Lucas and Lourenço, Olga and Papadopoulos, Nikolaos G and Pereira, Ana Margarida and Savouré, Marine and Toppila-Salmi, Sanna K and Ventura, Maria Teresa and Yepes-Nuñez, Juan José and Cruz, Alvaro A and Ciprandi, Giorgio and Gemicioglu, Bilun and Giovannini, Mattia and Gradauskiene, Brigita and Jartti, Tuomas and Jeseňák, Miloš and Kuna, Piotr and Kvedariene, Violeta and Larenas-Linnemann, Désirée E and Latiff, Amir H A and Mohammad, Yousser and Ohta, Ken and Mahesh, Padukudru A and Pali-Schöll, Isabella and Pfaar, Oliver and Regateiro, Frederico S and Roche, Nicolas and Taborda-Barata, Luís and Ulrik, Charlotte Suppli and Viegi, Giovanni and Zhang, Luo and Haahtela, Tari and Cherrez-Ojeda, Ivan and Ivancevich, Juan Carlos and Khaltaev, Nikolai and Yorgancioglu, Arzu and Abdullah, Baharudin and Al-Ahmad, Mona and Al-Nesf, Maryam Ali and Amaral, Rita and Asllani, Julijana},
title = {Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐ EAACI Guidelines—2024–2025 Revision: Part II —Guidelines on Oral and Ocular Treatments},
journal = {Allergy},
year = {2026},
volume = {81},
number = {6},
pages = {1947--1970},
doi = {10.1111/all.70305}
}
EUVIMED